Reduced Mg2+ inhibition of Ca2+ release in muscle fibers of pigs susceptible to malignant hyperthermia

American Journal of Physiology - Cell Physiology

Volumn 272, Issue 1 41-1, 1997, Pages

  Owen, V J ^a   Taske, N L ^b   Lamb, G D ^a  

^a LA TROBE UNIVERSITY   (Australia)

^b AUSTRALIAN NATIONAL UNIVERSITY   (Australia)

Author keywords

calcium release channel; dantrolene; skeletal muscle

Indexed keywords

CALCIUM CHANNEL; CALCIUM ION; DANTROLENE; MAGNESIUM ION; CAFFEINE; CALCIUM; CALCIUM CHANNEL BLOCKING AGENT; HALOTHANE; MAGNESIUM;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; CELL MEMBRANE TRANSPORT; CONTROLLED STUDY; MALIGNANT HYPERTHERMIA; MUSCLE RIGIDITY; NONHUMAN; PRIORITY JOURNAL; SARCOPLASMIC RETICULUM; SWINE; TRANSPORT KINETICS; ANIMAL; DRUG EFFECT; GENETIC PREDISPOSITION; GENETICS; GENOTYPE; METABOLISM; MUSCLE CELL; MUSCLE CONTRACTION; OSMOLARITY; PHYSIOLOGY;

ANIMALS; CAFFEINE; CALCIUM; CALCIUM CHANNEL BLOCKERS; DANTROLENE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HALOTHANE; MAGNESIUM; MALIGNANT HYPERTHERMIA; MUSCLE CONTRACTION; MUSCLE FIBERS; OSMOLAR CONCENTRATION; SWINE;

EID: 0030639279     PISSN: 03636143     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpcell.1997.272.1.c203     Document Type: Article

References (37)

1. Allen, G. C., J. E. Fletcher, F. J. Huggins, P. A. Conti, and H. Rosenberg. Caffeine and halothane contracture testing in swine using the recommendations of the North American Malignant Hyperthermia Group. Anesthesiology 72: 71-76, 1990.
2. 2+ release from sarcoplasmic reticulum of malignant hyperthermia susceptible pigs. Biochim. Biophys. Acta 1064: 175-183, 1991.
3. Coronado, R., J. Morrissette, M. Sukhareva, and D. M. Vaughan. Structure and function of ryanodine receptors. Am. J. Physiol. 266(Cell Physiol. 35): C1485-C1504, 1994.
4. El-Hayek, R., M. Yano, B. Antoniu, J. R. Mickelson, C. F. Louis, and N. Ikemoto. Altered E-C coupling in triads isolated from malignant hyperthermia-susceptible porcine muscle. Am. J. Physiol. 268 (Cell Physiol. 37): C1381-C1386, 1995.
5. Fill, M., R. Coronado, J. R. Mickelson, J. Vilven, J. Ma, B. A. Jacobson, and C. F. Louis. Abnormal ryanodine receptor channels in malignant hyperthermia. Biophys. J. 50: 471-475, 1990.
6. Fink, R. H. A., D. G. Stephenson, and D. A. Williams. Potassium and ionic strength effects on the isometric force of skinned twitch muscle fibres of the rat and toad. J. Physiol. Lond. 434: 507-528, 1986.
7. Fletcher, J. E., P. A. Calvo, and H. Rosenberg. Phenotypes associated with malignant hyperthermia susceptibility in swine genotyped as homozygous or heterozygous for the ryanodine receptor mutation. Br. J. Anaesth. 71: 410-417, 1993.
8. 2+-dependent ATPase activity on malignant hyperpyrexia-susceptible porcine skeletal muscle. Clin. Exp. Pharmacol. Physiol. 18: 489-495, 1991.
9. Fujii, J., K. Otsu, F. Zorzato, S. de Leon, V. K. Khanna, J. E. Weiler, P. J. O'Brien, and D. H. MacLennan. Identification of a mutation in porcine ryanodine receptor associated with malignant hyperthermia. Science Wash. DC 253: 448-451, 1991.
10. Gallant, E. M., and L. R. Lentz. Excitation-contraction coupling in pigs heterozygous for malignant hyperthermia. Am. J. Physiol. 262 (Cell Physiol. 31): C422-C426, 1992.
11. 2+-release channel in malignant hyperthermia. J. Biol. Chem. 267: 6702-6709, 1992.
12. 2+ inhibition and malignant hyperthermia. J. Muscle Res. Cell Motil. 14: 554-556, 1993.
13. Lamb, G. D., K. C. Hopkinson, and M. A. Denborough. Calcium currents and asymmetric charge movement in malignant hyperpyrexia. Muscle Nerve 12: 135-140, 1989.
14. 2+ release in skeletal muscle fibres of the toad. J. Physiol. Lond. 434: 507-528, 1991.
15. 2+ in excitation-contraction coupling in skeletal muscle. News Physiol. Sci. 7: 270-274, 1992.
16. 2+] on the excitation-contraction coupling in skeletal muscle fibres of the rat. J. Physiol. Lond. 478: 331-339, 1994.
17. 2+ channels from cardiac and skeletal muscle (Abstract). Biophys J. 70: A387, 1996.
18. 2+-selective microelectrodes. Muscle Nerve 9: 85-86, 1986.
19. MacLennan, D. H., and M. S. Phillips. Malignant hyperthermia. Science Wash. DC 256: 789-794, 1992.
20. 2+, and adenine nucleotides. Biochemistry 25: 236-244, 1986.
21. Mickelson, J. R., J. M. Ervasti, L. A. Litterer, K. P. Campbell, and C. F. Louis. Skeletal muscle junctional membrane protein content in pigs with different ryanodine receptor genotypes. Am. J. Physiol. 267 (Cell Physiol. 36): C282-C292, 1994.
22. Mickelson, J. R., E. M. Gallant, W. E. Rempel, K. M. Johnson, L. A. Litterer, B. A. Jacobson, and C. F. Louis. Effects of halothane-sensitivity gene on sarcoplasmic reticulum function. Am. J. Physiol. 257 (Cell Physiol. 26): C787-C794, 1989.
23. 3H]ryanodine binding to sarcoplasmic reticulum from malignant hyperthermia susceptible pigs. Arch. Biochem. Biophys. 278: 251-257, 1990.
24. Nelson, T. E. SR function in malignant hyperthermia. Cell Calcium 9: 257-265, 1988.
25. ++ regulatory site defect in sarcoplasmic reticulum from malignant hyperthermia pig muscle. J. Pharmacol. Exp. Ther. 256: 645-649, 1991.
26. O'Brien, P. J. Porcine malignant hyperthermia susceptibility: hypersensitive calcium-release mechanism of skeletal muscle sarcoplasmic reticulum. Can. J. Vet. Res. 50: 318-328, 1986.
27. Ohnishi, S. T., A. J. Waring, S.-R. G. Fang, K. Horiuchi, J. L. Flick, K. K. Sadanaga, and T. Ohnishi. Abnormal membrane properties of the sarcoplasmic reticulum of pigs susceptible to malignant hyperthermia: modes of action of halothane, caffeine, dantrolene, and two other drugs. Arch. Biochem. Biophys. 247: 294-301, 1986.
28. Ohta, T., M. Endo, T. Nakano, Y. Morohoshi, K. Wanikawa, and A. Ohga. Ca-induced Ca release in malignant hyperthermia-susceptible pig skeletal muscle. Am. J. Physiol. 256 (Cell Physiol. 25): C358-C367, 1989.
29. Okumura, F., B. D. Crocker, and M. A. Denborough. Identification of susceptibility to malignant hyperpyrexia in swine. Br. J. Anaesth. 51: 171-176, 1979.
30. Otsu, K., M. S. Phillips, V. K. Khanna, S. De Leon, and D. H. MacLennan. Refinement of diagnostic assays for a probable causal mutation for porcine and human malignant hyperthermia. Genomics 13: 835-837, 1992.
31. 2+ release in skeletal muscle fibres of the toad. J. Physiol. Lond. 493: 309-315, 1996.
32. Seewald, M. J., H. M. Eichinger, F. Lehmann-Horn, and P.A. Iaizzo. Characterization of swine susceptible to malignant hyperthermia by in vivo, in vitro and post-mortem techniques. Acta Anaesthesiol. Scand. 35: 345-349, 1991.
33. Shomer, N. H., C. F. Louis, M. Fill, L. A. Litterer, and J. R. Mickelson. Reconstitution of abnormalities in the malignant hyperthermia-susceptible pig ryanodine receptor. Am. J. Physiol. 264 (Cell Physiol. 33): C125-C135, 1993.
34. 2+. J. Membr. Biol. 146: 133-144, 1995.
35. Stephenson, G. M. M., A. O'Callaghan, and D. G. Stephenson. Single fibre study of contractile and biochemical properties of skeletal muscles in streptozotocin-induced diabetic rats. Diabetes 43: 622-628, 1994.
36. 2+ release channel (Abstract). Biophys. J. 70: A168, 1996.
37. 2+ concentration during repetitive stimulation of single fibres from mouse skeletal muscle. J. Physiol. Lond. 453: 413-434, 1992.